Literature DB >> 21742381

Treatment-induced manic switch in the course of unipolar depression can predict bipolarity: cluster analysis based evidence.

Kemal Dumlu1, Zahide Orhon, Ayşegül Özerdem, Umit Tural, Halis Ulaş, Zeliha Tunca.   

Abstract

BACKGROUND: Antidepressants are known to induce manic switch in patients with depression. Treatment-induced mania is not considered as bipolar disorder in DSM IV. The aim of this study was to assess whether clinical characteristics of patients with unipolar depression with a history of treatment-induced mania were similar to those of patients with bipolar disorder.
METHOD: The study included 217 consecutive patients with DSM-IV mood disorders, diagnosed as: bipolar disorder type I (BP-I, n = 58) or type II (BP-II, n = 18) whose first episodes were depression, recurrent (unipolar) major depressive disorder with a history of antidepressant treatment-induced mania (switchers = sUD; n = 61) and without such an event (rUD; n = 80). First, the groups were compared with regard to clinical features and course specifiers using variance and chi-square analysis. Variables that differed significantly between the four groups were included in two-step cluster analysis to explore naturally occurring subgroups in all diagnoses. Subsequently, the relationship between the naturally occurring clusters and pre-defined DSM-IV diagnoses were investigated.
RESULTS: Two-step cluster analysis revealed two different naturally occurring groups. Higher severity of depressive episodes, with higher rate of melancholic features, higher number of hospitalization and suicide attempts were represented in one cluster where switchers (77%), bipolar I (94.8%) and II (83.3%) patients clustered together.
CONCLUSION: The findings of this study confirm that treatment-induced mania is a clinical phenomenon that belongs within the bipolar spectrum rather than a coincidental treatment complication, and that it should be placed under "bipolar disorders" in future classification systems. LIMITATIONS: The study includes the limitations of any naturalistic retrospective study.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742381     DOI: 10.1016/j.jad.2011.06.019

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  DSM-5 and Mental Disorders in Older Individuals: An Overview.

Authors:  Perminder S Sachdev; Adith Mohan; Lauren Taylor; Dilip V Jeste
Journal:  Harv Rev Psychiatry       Date:  2015 Sep-Oct       Impact factor: 3.732

2.  Antidepressant-induced mania or hypomania in DSM-5.

Authors:  Takeshi Terao; Teruaki Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2013-11-19       Impact factor: 4.530

Review 3.  Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5.

Authors:  Kazuyoshi Ogasawara; Yukako Nakamura; Hiroyuki Kimura; Branko Aleksic; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2017-12-23       Impact factor: 3.575

4.  Electroencephalography Source Functional Connectivity Reveals Abnormal High-Frequency Communication Among Large-Scale Functional Networks in Depression.

Authors:  Alexis E Whitton; Stephanie Deccy; Manon L Ironside; Poornima Kumar; Miranda Beltzer; Diego A Pizzagalli
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-07-13

5.  Are There Executive Dysfunction Subtypes Within ADHD?

Authors:  Bethan A Roberts; Michelle M Martel; Joel T Nigg
Journal:  J Atten Disord       Date:  2016-07-28       Impact factor: 3.256

6.  A Predictive Model of Risk Factors for Conversion From Major Depressive Disorder to Bipolar Disorder Based on Clinical Characteristics and Circadian Rhythm Gene Polymorphisms.

Authors:  Zhi Xu; Lei Chen; Yunyun Hu; Tian Shen; Zimu Chen; Tingting Tan; Chenjie Gao; Suzhen Chen; Wenji Chen; Bingwei Chen; Yonggui Yuan; Zhijun Zhang
Journal:  Front Psychiatry       Date:  2022-07-11       Impact factor: 5.435

7.  Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series.

Authors:  Yasunari Yamaguchi; Sohei Kimoto; Takeshi Nagahama; Toshifumi Kishimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-17       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.